0
0
Read Time:3 Minute, 48 Second
Continuous Bioprocessing Market is projected to reach $1.32 billion by 2031 at a CAGR of 19.6% from 2024 to 2031.
The Continuous Bioprocessing Market is anticipated to grow to $1.32 billion by 2031, with a remarkable compound annual growth rate (CAGR) of 19.6% during the forecast period, according to Meticulous Research®. Continuous bioprocessing represents a streamlined approach in biomanufacturing, where raw materials are processed within a single unit to yield the final product.
Download Complete Sample PDF Copy Here: https://meticulousresearch.com/download-sample-report/cp_id=5079
The main objectives of this method are to minimize manufacturing costs, enhance facility output, and accelerate the production of biopharmaceuticals. Continuous bioprocessing is crucial for the commercial production of monoclonal antibodies (mAbs), cell and gene therapies, vaccines, and recombinant proteins.
Market Drivers and Challenges
The expansion of the continuous bioprocessing market is primarily driven by:- Increased Demand for Biopharmaceuticals: A surge in the global demand for innovative biopharmaceutical products is pushing manufacturers to adopt continuous bioprocessing.
- Emergence of Continuous End-to-End Bioprocessing: This integrated approach enhances efficiency and reduces production time.
- Global Initiatives Supporting Biopharmaceutical Adoption: Various government and international bodies are promoting the use of biopharmaceuticals, contributing to market growth.
- Advantages Over Fed-Batch Processes: Continuous manufacturing offers several benefits, including improved product consistency and reduced downtime.
Top 10 Companies in the Continuous Bioprocessing Market
- 3M Company (U.S.)
- Founded in 1902 and headquartered in Minnesota, 3M is a global leader in product development and manufacturing across various sectors, including healthcare and industrial safety. Their Health Care segment offers an extensive range of filtration products tailored for biopharmaceutical applications, emphasizing separation and purification.
- Thermo Fisher Scientific Inc. (U.S.)
- Established in 1956, Thermo Fisher is a major player in life sciences, providing solutions that enhance research and diagnostics. Their bioproduction offerings encompass a variety of single-use technologies and scalable solutions for cell therapy manufacturing.
- Sartorius AG (Germany)
- Founded in 1870, Sartorius specializes in biopharmaceutical R&D and manufacturing. Their Bioprocess Solutions division delivers a broad array of products, including bioreactors and cell culture media, backed by a robust production network across Europe and beyond.
- Eppendorf AG (Germany)
- Operating since 1945, Eppendorf manufactures laboratory instruments and consumables. The company offers a range of products, including bioreactors and centrifuges, serving clients in over 26 countries.
- Danaher Corporation (U.S.)
- Established in 1969, Danaher operates through subsidiaries like Pall Corporation and Cytiva, providing advanced filtration and purification technologies essential for the development of therapeutic products.
- Merck KGaA (Germany)
- Founded in 1668, Merck KGaA focuses on improving health through science and technology. Their Process Solutions segment delivers continuous bioprocessing technologies across a global manufacturing footprint.
- Repligen Corporation (U.S.)
- Founded in 1981, Repligen specializes in innovative bioprocessing technologies, with a diverse portfolio covering filtration, chromatography, and process analytics, primarily catering to the biopharmaceutical industry.
- Getinge AB (Sweden)
- Established in 1904, Getinge enhances bioprocessing through its subsidiary, Applikon Biotechnology, which provides advanced bioreactor systems and solutions for the pharmaceutical and biotechnology sectors.
- Bionet (Spain)
- Founded in 1999, Bionet manufactures equipment and software for the bioprocessing industry, specializing in automation solutions and complete bioproduction plants. The company is involved in various R&D initiatives and maintains a commitment to quality management.
- Corning Inc. (U.S.)
- With roots dating back to 1851, Corning leverages its expertise in glass and ceramic science to provide a range of life sciences solutions. Their product offerings include cell culture media, labware, and consumables, supported by an extensive global presence.
Conclusion
The continuous bioprocessing market is poised for significant growth, driven by technological advancements and increasing demand for biopharmaceuticals. As companies continue to innovate and adapt to the evolving landscape, they must navigate challenges while capitalizing on emerging opportunities. Quick buy: https://www.meticulousresearch.com/product/continuous-bioprocessing-market-5079 Contact Us: Meticulous Market Research Pvt. Ltd. 1267 Willis St, Ste 200 Redding, California, 96001, U.S. USA: +1-646-781-8004 Europe : +44-203-868-8738 APAC: +91 744-7780008 Email- sales@meticulousresearch.com Visit Our Website: https://www.meticulousresearch.com/ Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-researchAbout Post Author
Meticulous Research
Average Rating
5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%